The Open Issues Regarding Cyclin-Dependent Kinase 4/6 Inhibitors in the Management of Advanced Breast Cancer

被引：1
|
作者：
Rossi, Lorenzo [1 ,2 ]
机构：
[1] Inst Oncol Southern Switzerland, Bellinzona, Switzerland
[2] Breast Unit Southern Switzerland, Lugano, Switzerland
来源：
JOURNAL OF BREAST CANCER | 2018年 / 21卷 / 04期
关键词：
RESISTANCE;
D O I：
10.4048/jbc.2018.21.e59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：468 / 470
页数：3
相关论文
共 50 条
  • [1] Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women
    Cersosimo, Robert J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (16) : 1183 - 1202
  • [2] Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
    Micha, John P.
    Rettenmaier, Mark A.
    Bohart, Randy D.
    Goldstein, Bram H.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 547 - 551
  • [3] Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer
    Hassan, Mohammed Al-Kassim
    Ates-Alagoz, Zeynep
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 412 - 428
  • [4] Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy
    Migliaccio, Ilenia
    Di Leo, Angelo
    Malorni, Luca
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 568 - 575
  • [5] Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
    Husinka, Lakyn
    Koerner, Pamela H.
    Miller, Rick T.
    Trombatt, William
    [J]. JOURNAL OF DRUG ASSESSMENT, 2021, 10 (01) : 27 - 34
  • [6] Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer
    Takahashi, Kaori
    Uozumi, Ryuji
    Mukohara, Toru
    Hayashida, Tetsu
    Iwabe, Midori
    Iihara, Hirotoshi
    Kusuhara-Mamishin, Kanako
    Kitagawa, Yuko
    Tsuchiya, Masami
    Kitahora, Mika
    Nagayama, Aiko
    Kosaka, Shinkichi
    Asano-Niwa, Yoshimi
    Seki, Tomoko
    Ohnuki, Koji
    Suzuki, Akio
    Ono, Fumiko
    Futamura, Manabu
    Kawazoe, Hitoshi
    Nakamura, Tomonori
    [J]. ONCOLOGIST, 2024, 29 (06): : e741 - e749
  • [7] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Dorota Kwapisz
    [J]. Breast Cancer Research and Treatment, 2017, 166 : 41 - 54
  • [8] Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced oestrogen receptor-positive breast cancer
    Dubianski, Roman
    Jagiello-Gruszfeld, Agnieszka
    Nowecki, Zbigniew
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2016, 12 (06): : 209 - 214
  • [9] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Kwapisz, Dorota
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 41 - 54
  • [10] Cyclin-Dependent Kinase 4 and 6 Inhibitors: A Quantum Leap in the Treatment of Advanced Breast Cancers
    Reddy, Sanjana
    Barkhane, Zineb
    Elmadi, Jalal
    Kumar, Lakshmi Satish
    Pugalenthi, Lakshmi Sree
    Ahmad, Mahlika
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
12345